valproic acid has been researched along with ciproxifan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bambini-Junior, V; Baronio, D; Castro, K; de Melo, GM; Gonchoroski, T; Gottfried, C; Nunes, GD; Riesgo, R | 1 |
| Esmaeilpour, K; Maneshian, M; Sepehri, G; Sheibani, V; Taheri, F; Ur Rehman, N | 1 |
| Esmaeilpour, K; Sepehri, G; Sheibani, V; Shekari, MA; Taheri, F | 1 |
3 other study(ies) available for valproic acid and ciproxifan
| Article | Year |
|---|---|
Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid.
Topics: Animals; Autistic Disorder; Behavior, Animal; Disease Models, Animal; Female; Histamine Antagonists; Imidazoles; Mice; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Histamine H3; Valproic Acid | 2015 |
Histamine H3 receptor antagonist, ciproxifan, alleviates cognition and synaptic plasticity alterations in a valproic acid-induced animal model of autism.
Topics: Animals; Autism Spectrum Disorder; Autistic Disorder; Cognition; Disease Models, Animal; Female; Histamine H3 Antagonists; Humans; Imidazoles; Memory Disorders; Neuronal Plasticity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Spatial Learning; Valproic Acid | 2022 |
Amelioration of cognition impairments in the valproic acid-induced animal model of autism by ciproxifan, a histamine H3-receptor antagonist.
Topics: Animals; Autism Spectrum Disorder; Autistic Disorder; Behavior, Animal; Cognition; Cognitive Dysfunction; Disease Models, Animal; Female; Histamine; Histamine H3 Antagonists; Humans; Prenatal Exposure Delayed Effects; Rats; Social Behavior; Valproic Acid | 2023 |